News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TearScience, Inc.’s LipiFlow® Multi-center Clinical Study Shows Improved Meibomian Gland Secretions and Dry Eye Symptoms



3/5/2012 7:38:57 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--The results of a randomized, controlled clinical study of a new treatment for Meibomian Gland Dysfunction (MGD) and evaporative dry eye disease, using the LipiFlow® Thermal Pulsation System, was reported in Cornea to provide sustained improvement, on average, in both signs and symptoms. Further, this study demonstrated the clinical utility, safety and effectiveness of LipiFlow® in adult patients with MGD and dry eye symptoms.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES